Yuyu Pharma Inc (KO:000227) — Market Cap & Net Worth
Market Cap & Net Worth: Yuyu Pharma Inc (000227)
Yuyu Pharma Inc (KO:000227) has a market capitalization of $30.10 Million (₩44.42 Billion) as of September 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #23877 globally and #1655 in its home market, demonstrating a -0.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuyu Pharma Inc's stock price ₩7580.00 by its total outstanding shares 5859680 (5.86 Million). Also see Yuyu Pharma Inc asset portfolio for a full breakdown of the balance sheet.
Yuyu Pharma Inc Market Cap History: 2015 to 2026
Yuyu Pharma Inc's market capitalization history from 2015 to 2026. Data shows change from $33.28 Million to $30.10 Million (-1.72% CAGR). Also see 000227 cash flow metrics for how efficiently the company converts equity into cash flow.
Yuyu Pharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuyu Pharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 000227 live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Yuyu Pharma Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Yuyu Pharma Inc's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $33.28 Million | $69.74 Billion | -$252.68 Million | 0.00x | N/A |
| 2016 | $23.14 Million | $71.58 Billion | $5.89 Billion | 0.00x | 0.00x |
| 2017 | $35.44 Million | $62.85 Billion | $4.54 Billion | 0.00x | 0.01x |
| 2018 | $33.19 Million | $83.10 Billion | $4.02 Billion | 0.00x | 0.01x |
| 2019 | $36.60 Million | $90.88 Billion | $4.72 Billion | 0.00x | 0.01x |
| 2020 | $65.26 Million | $98.12 Billion | $1.28 Billion | 0.00x | 0.05x |
| 2021 | $70.96 Million | $115.66 Billion | -$2.21 Billion | 0.00x | N/A |
| 2022 | $59.76 Million | $138.88 Billion | -$5.99 Billion | 0.00x | N/A |
| 2023 | $48.76 Million | $137.21 Billion | -$7.18 Billion | 0.00x | N/A |
| 2024 | $38.04 Million | $133.15 Billion | $8.72 Billion | 0.00x | 0.00x |
Competitor Companies of 000227 by Market Capitalization
Companies near Yuyu Pharma Inc in the global market cap rankings as of September 18, 2026. Review 000227 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Yuyu Pharma Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #520 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #619 globally with a market cap of $44.48 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #637 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Haleon plc (NYSE:HLN): Ranked #665 globally with a market cap of $41.22 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #520 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #619 | GALDERMA GROUP AG | NYSE:GALDY | $44.48 Billion | $38.15 |
| #637 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.10 |
| #665 | Haleon plc | NYSE:HLN | $41.22 Billion | $9.36 |
Yuyu Pharma Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Yuyu Pharma Inc's market cap moved from $33.28 Million to $ 30.10 Million, with a yearly change of -1.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩30.10 Million | -32.20% |
| 2025 | ₩44.40 Million | +16.70% |
| 2024 | ₩38.04 Million | -21.99% |
| 2023 | ₩48.76 Million | -18.41% |
| 2022 | ₩59.76 Million | -15.78% |
| 2021 | ₩70.96 Million | +8.74% |
| 2020 | ₩65.26 Million | +78.31% |
| 2019 | ₩36.60 Million | +10.27% |
| 2018 | ₩33.19 Million | -6.34% |
| 2017 | ₩35.44 Million | +53.13% |
| 2016 | ₩23.14 Million | -30.45% |
| 2015 | ₩33.28 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Yuyu Pharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.10 Million USD |
| MoneyControl | $30.10 Million USD |
| MarketWatch | $30.10 Million USD |
| marketcap.company | $30.10 Million USD |
| Reuters | $30.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yuyu Pharma Inc
Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc.… Read more